AR
Ajit Rajaram Kantak
About Ajit Rajaram Kantak
Data last updated:
Ajit Rajaram Kantak is a Director at Sandu Pharmaceuticals Limited (since 2023). The company operates in Healthcare. Sandu Pharmaceuticals Limited reported revenue of ₹67.36 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sandu Pharmaceuticals Limited L24233GA1985PLC001587 | Director | 14 Aug 2023 | 1985 | ₹67.36 Cr (FY 2025) | Active |
Board colleagues of Ajit Rajaram Kantak
| Name | DIN | Company | Designation |
|---|---|---|---|
| Balram Viswanathan | 10245195 | Sandu Pharmaceuticals Limited | Director |
| Jayshree Bhasker Sandu | 07480177 | Sandu Pharmaceuticals Limited | Director |
| Pratika Mhambray | Sandu Pharmaceuticals Limited | Company Secretary | |
| Shashank Bhaskar Sandu | 00678098 | Sandu Pharmaceuticals Limited | Director |
| Vijay Kottapalli | 10245156 | Sandu Pharmaceuticals Limited | Director |
| Vijay Yashwant Kajarekar | Sandu Pharmaceuticals Limited | Cfo |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ajit Rajaram Kantak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ajit Rajaram Kantak
Ajit Rajaram Kantak currently holds 1 directorship: Sandu Pharmaceuticals Limited (Director, since 14 Aug 2023, revenue ₹67.36 Cr (FY 2025)).
Ajit Rajaram Kantak was first appointed on 14 Aug 2023 as Director at Sandu Pharmaceuticals Limited.
The current boards of Ajit Rajaram Kantak's companies include Balram Viswanathan (Sandu Pharmaceuticals Limited), Jayshree Bhasker Sandu (Sandu Pharmaceuticals Limited), Pratika Mhambray (Sandu Pharmaceuticals Limited), Shashank Bhaskar Sandu (Sandu Pharmaceuticals Limited), Vijay Kottapalli (Sandu Pharmaceuticals Limited), Vijay Yashwant Kajarekar (Sandu Pharmaceuticals Limited).